- Home
- PPBT vs IPDN Comparison
PPBT vs IPDN Comparison
Compare PPBT & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- IPDN
- Stock Information
- Founded
- PPBT 2010
- IPDN 2003
- Country
- PPBT Israel
- IPDN United States
- Employees
- PPBT N/A
- IPDN N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- IPDN EDP Services
- Sector
- PPBT Health Care
- IPDN Technology
- Exchange
- PPBT Nasdaq
- IPDN Nasdaq
- Market Cap
- PPBT 5.5M
- IPDN 5.2M
- IPO Year
- PPBT N/A
- IPDN 2013
- Fundamental
- Price
- PPBT $0.59
- IPDN $3.48
- Analyst Decision
- PPBT Strong Buy
- IPDN
- Analyst Count
- PPBT 1
- IPDN 0
- Target Price
- PPBT $33.00
- IPDN N/A
- AVG Volume (30 Days)
- PPBT 234.5K
- IPDN 198.1K
- Earning Date
- PPBT 11-14-2025
- IPDN 11-13-2025
- Dividend Yield
- PPBT N/A
- IPDN N/A
- EPS Growth
- PPBT N/A
- IPDN N/A
- EPS
- PPBT N/A
- IPDN N/A
- Revenue
- PPBT N/A
- IPDN $6,459,379.00
- Revenue This Year
- PPBT N/A
- IPDN N/A
- Revenue Next Year
- PPBT N/A
- IPDN N/A
- P/E Ratio
- PPBT N/A
- IPDN N/A
- Revenue Growth
- PPBT N/A
- IPDN N/A
- 52 Week Low
- PPBT $0.53
- IPDN $0.97
- 52 Week High
- PPBT $13.95
- IPDN $12.39
- Technical
- Relative Strength Index (RSI)
- PPBT 29.54
- IPDN 48.37
- Support Level
- PPBT $0.56
- IPDN $3.30
- Resistance Level
- PPBT $0.66
- IPDN $3.83
- Average True Range (ATR)
- PPBT 0.04
- IPDN 0.39
- MACD
- PPBT 0.05
- IPDN -0.04
- Stochastic Oscillator
- PPBT 29.11
- IPDN 39.23
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.